Keywords: واکسن تب زرد; Yellow fever vaccine; Immunogenicity; Dose-response study; Duration of immunity; Fractionated vaccine;
مقالات ISI واکسن تب زرد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: واکسن تب زرد; Yellow fever vaccine; Serious adverse events; Chimeri-JYF; Japanese encephalitis virus; Safe; Protection;
Keywords: واکسن تب زرد; Yellow fever; Yellow fever vaccine; Immunization; Safety; Hemodialysis; Chronic kidney disease
Keywords: واکسن تب زرد; Vaccines; Yellow fever vaccine; Viral vector; Brighton Collaboration; Risk/benefit assessment; Vaccine safety;
Keywords: واکسن تب زرد; Yellow fever vaccine; Safety; Argentina; Severe adverse events;
Keywords: واکسن تب زرد; ADEM; acute disseminated encephalomyelitis; AEFI; adverse event following immunization; CDC; Centers for Disease and Control, USA; CSF; cerebrospinal fluid; CIFAVI; Interinstitutional Committee for Evaluation of Adverse Events at the Brazilian Ministry of
Keywords: واکسن تب زرد; Yellow fever vaccine; Immunogenicity; Vaccination policy;
Keywords: واکسن تب زرد; YF; yellow fever; YEL-AVD; yellow fever vaccine-associated viscerotropic disease; RR; reporting rates; RRR; reporting rate ratios; AVD; viscerotropic disease; AEFI; adverse events following immunization; serious AEFI; serious adverse events following immu
Keywords: واکسن تب زرد; ADEM; acute disseminated encephalomyelitis; AEFI; adverse event following immunization; CSF; cerebrospinal fluid; ELISA; enzyme-linked immunosorbent assay; IFA; immunofluorescent antibody; NEC; national expert committee; PV; pharmacovigilance; RKI; Robert
Safety profile of fractional dosing of the 17DD Yellow Fever Vaccine among males and females: Experience of a community-based pharmacovigilance in Kinshasa, DR Congo
Keywords: واکسن تب زرد; Yellow Fever Vaccine; Fractional dosing; Vaccine safety; Adverse Events Following Immunization; Gender; Democratic Republic of Congo;
Yellow fever vaccine-associated neurotropic disease (YEL-AND) - A case report
Keywords: واکسن تب زرد; Yellow fever vaccine; Adverse event; Neurological disease;
CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles
Keywords: واکسن تب زرد; Yellow fever vaccine; Measles vaccine; Immunization; Travelling children; Administration schedule;
Is the absence or intermittent YF vaccination the major contributor to its persistent outbreaks in eastern Africa?
Keywords: واکسن تب زرد; Yellow fever vaccine; Yellow fever; Outbreak; Virus; Eastern Africa;
Gestational exposure to yellow fever vaccine at different developmental stages induces behavioral alterations in the progeny
Keywords: واکسن تب زرد; Yellow fever vaccine; Yellow fever virus; Gestation; Neurotoxicity; Behavior; Maternal immunization
How many published cases of serious adverse events after yellow fever vaccination meet Brighton Collaboration diagnostic criteria?
Keywords: واکسن تب زرد; Yellow fever vaccine; Serious adverse events; Systematic review; Brighton Collaboration criteria
Yellow fever vaccine: Comparison of the neurovirulence of new 17D-204 Stamaril™ seed lots and RK 168-73 strain
Keywords: واکسن تب زرد; Yellow fever vaccine; Seeds; 17D-204 Stamaril™; RK 168-73; Vaccine characterization; NeurovirulenceYF, yellow fever; FNV, French neurotropic vaccine; YEL-AND, Yellow Fever Vaccine-Associated Neurotropic Disease; YEL-AVD, Yellow Fever Vaccine-Associated Vi
The yellow fever 17D vaccine and risk of malignant melanoma in the United States military
Keywords: واکسن تب زرد; Melanoma; Yellow fever vaccine; Nested case-control study;
Immunogenicity and safety of tetravalent dengue vaccine in 2-11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru
Keywords: واکسن تب زرد; Flavivirus vaccine; Live vaccine; Children; Tetravalent dengue vaccine; Yellow fever vaccine; Phase II clinical trial;
Viscerotropic disease: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
Keywords: واکسن تب زرد; AEFI; adverse event following immunization; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BP; blood pressure; CDC; Centers for Disease Control and Prevention (US); CPK; creatine phosphokinase; DIC; disseminated intravascular coagulation;
Neurovirulence tests of three 17D yellow fever vaccine strains
Keywords: واکسن تب زرد; Yellow fever vaccine; Seeds; Neurovirulence
Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella
Keywords: واکسن تب زرد; Yellow fever vaccine; Combined vaccine against measles; Rubella and mumps; Immunogenicity; Reactogenicity; Brazil;
Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: Systematic review
Keywords: واکسن تب زرد; AEFI; adverse event following immunization; PCR; polymerase chain reaction; YEL-AND; yellow-fever associated neurologic disease; YEL-AVD; yellow-fever associated viscerotropic disease; YFV; yellow fever vaccine; Yellow fever; Yellow fever 17D and 17DD vac
Is it time for a new yellow fever vaccine?
Keywords: واکسن تب زرد; Yellow fever; Yellow fever vaccine; Global health; Traveler's health; Flavivirus vaccine
CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-γ at 5–7 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses
Keywords: واکسن تب زرد; Yellow fever vaccine; IFN-γ; Rhesus model
WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13–14 May 2009
Keywords: واکسن تب زرد; Yellow fever vaccine; World Health Organization; Recommendations
Does yellow fever 17D vaccine protect against melanoma?
Keywords: واکسن تب زرد; Melanoma; Yellow fever vaccine; Cohort study; Nested case-control study; Cancer prevention
Monitoring adverse events following yellow fever vaccination using an integrated telephone and Internet-based system
Keywords: واکسن تب زرد; Yellow fever; Yellow fever vaccine; Adverse events; Health surveys
TLR expression and NK cell activation after human yellow fever vaccination
Keywords: واکسن تب زرد; Yellow fever vaccine; Natural killer cells; Toll-like receptors
Viscerotropic disease following yellow fever vaccination in Peru
Keywords: واکسن تب زرد; Yellow fever vaccine; Viscerotropic disease; Vaccine safety; Yellow fever; Arbovirus
Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999–2005
Keywords: واکسن تب زرد; Yellow fever vaccine; Adverse effects; Adverse events following immunization; Brazil; Mass vaccination campaign
Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: Implications for the Brazilian National Immunization Program
Keywords: واکسن تب زرد; Yellow fever vaccine; Clinical trials; Randomized controlled trials
Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 cases
Keywords: واکسن تب زرد; Adverse event; Neurologic; Yellow fever vaccine
High stability of yellow fever 17D-204 vaccine: A 12-year restrospective analysis of large-scale production
Keywords: واکسن تب زرد; Yellow fever vaccine; Virus stability; Vaccine characterization
Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine
Keywords: واکسن تب زرد; Yellow fever vaccine; Booster; Neutralizing antibody
Yellow fever vaccine: An updated assessment of advanced age as a risk factor for serious adverse events
Keywords: واکسن تب زرد; Yellow fever vaccine; Vaccination/adverse effects; Adverse drug reaction reporting systems; Age groups